Literature DB >> 978003

Longitudinal studies of types A and B influenza among Seattle schoolchildren and families, 1968-74.

H M Foy, M K Cooney, I Allan.   

Abstract

Longitudinal studies of influenza were conducted by postepidemic collection of sera and illness information among Seattle schoolchildren from 1968 to 1974 and in family groups from 1972 to 1974. The rate of infection with A/Hong Kong (H3N2) virus was lowest in the 1968-1969 epidemic; rates were twice as high in the epidemics of 1970 and 1972, and in the A/England (H3N2) epidemic of 1973. The introduction of a new strain of influenza type A or type B caused higher rates of infection in junior high than elementary schoolchildren. For influenza A, a shift in strain was associated with higher rates in the urban area than in the suburban area. The proportion of adolescents with serological evidence of infection who reported typical illness was 40%-42% in all three A/Hong Kong epidemics and 54% during the A/England epidemic. Reinfection with the A/Hong Kong strain was rare. Recent natural infection with the A/Hong Kong virus (1972) afforded 62% protection in the 1973 epidemic of A/England influenza.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 978003     DOI: 10.1093/infdis/134.4.362

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  19 in total

1.  Evaluation of a cold-adapted influenza B/Texas/84 reassortant virus (CRB-87) vaccine in young children.

Authors:  E L Anderson; F K Newman; H F Maassab; R B Belshe
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

2.  Estimating the United States demand for influenza antivirals and the effect on severe influenza disease during a potential pandemic.

Authors:  Justin J O'Hagan; Karen K Wong; Angela P Campbell; Anita Patel; David L Swerdlow; Alicia M Fry; Lisa M Koonin; Martin I Meltzer
Journal:  Clin Infect Dis       Date:  2015-05-01       Impact factor: 9.079

3.  Improving the evidence base for decision making during a pandemic: the example of 2009 influenza A/H1N1.

Authors:  Marc Lipsitch; Lyn Finelli; Richard T Heffernan; Gabriel M Leung; Stephen C Redd
Journal:  Biosecur Bioterror       Date:  2011-06

4.  Description and evaluation of the 2009-2010 Pennsylvania Influenza Sentinel School Monitoring System.

Authors:  Vanessa L Short; Chandra K Marriott; Stephen Ostroff; Kirsten Waller
Journal:  Am J Public Health       Date:  2011-05-12       Impact factor: 9.308

5.  Association between antibody titers and protection against influenza virus infection within households.

Authors:  Tim K Tsang; Simon Cauchemez; Ranawaka A P M Perera; Guy Freeman; Vicky J Fang; Dennis K M Ip; Gabriel M Leung; Joseph Sriyal Malik Peiris; Benjamin J Cowling
Journal:  J Infect Dis       Date:  2014-03-26       Impact factor: 5.226

6.  The shifting demographic landscape of pandemic influenza.

Authors:  Shweta Bansal; Babak Pourbohloul; Nathaniel Hupert; Bryan Grenfell; Lauren Ancel Meyers
Journal:  PLoS One       Date:  2010-02-26       Impact factor: 3.240

7.  The severity of pandemic H1N1 influenza in the United States, from April to July 2009: a Bayesian analysis.

Authors:  Anne M Presanis; Daniela De Angelis; Angela Hagy; Carrie Reed; Steven Riley; Ben S Cooper; Lyn Finelli; Paul Biedrzycki; Marc Lipsitch
Journal:  PLoS Med       Date:  2009-12-08       Impact factor: 11.069

8.  A study of acute respiratory disease in the community of Port Chalmers. II. Influenza A/Port Chalmers/1/73: intrafamilial spread and the effect of antibodies to the surface antigens.

Authors:  L C Jennings; J A Miles
Journal:  J Hyg (Lond)       Date:  1978-08

9.  Concurrent outbreaks of influenza A and influenza B.

Authors:  D W Spelman; C J McHardy
Journal:  J Hyg (Lond)       Date:  1985-06

10.  [A new influenza subunit vaccine: hemagglutinating antibodies one year after vaccination (author's transl)].

Authors:  C Kunz; H Hofmann; A Moritz; H Bachmayer; E Liehl
Journal:  Infection       Date:  1978       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.